Navigation Links
Triessent(R) Becomes HCSC's Specialty Pharmacy Provider
Date:1/27/2009

ST. PAUL, Minn., Jan. 27 /PRNewswire/ -- Prime Therapeutics (Prime) announced today that Health Care Service Corporation (HCSC) has selected Triessent(R) as its primary specialty pharmacy program. On January 1, 2009, Prime began providing a portion of HCSC's health benefits business with specialty pharmacy services. By March 1, 2009, Prime will be providing specialty pharmacy services for HCSC's Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas.

The Triessent program helps clients address rising specialty costs by providing an approach to specialty pharmacy management that integrates across pharmacy and medical benefits. The Triessent program focuses on three core services as a foundation for complete specialty management: safe and efficient delivery of specialty medications; education and guidance from experienced professionals for managing specialty conditions and the benefits that apply to them; and an integrated approach that streamlines medical and pharmacy benefit management.

"Our relationship with our Blue Cross and Blue Shield clients ensures alignment of interests. Through Triessent, Prime can help our clients improve financial controls in this growing area without compromising a commitment to quality member care," says Tim Dickman, President and Chief Executive Officer, Prime.

"HCSC is excited to be able to partner with Prime in developing a comprehensive specialty program that is fully integrated with our medical management activities," said Kevin Slavik, Senior Pharmacy Director of HCSC. "With the implementation of Triessent, our members will experience the high-touch, personalized and coordinated care management they need to manage their health conditions."

Health Care Service Corporation is a Mutual Legal Reserve Company, an independent licensee of the Blue Cross and Blue Shield Association.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 11 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zumas Rescue Ranch becomes a Federal 501C3
2. MinuteClinic Becomes Participating Provider With Blue Cross and Blue Shield of Florida
3. Medscape Physician Connect Becomes Largest Online Physician Social Network with More than 100,000 Physicians
4. Dental Network of America Becomes Largest National Dental Network in the U.S.
5. Mega Pediatric Group Allows Doctors to Focus on Patient Care as the Business Side of Private Practice Becomes More Difficult to Sustain
6. When the Caregiver Becomes the Patient
7. Coors of Las Vegas Becomes New Distributor of RecoveryX
8. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
9. UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundations Research Campaign
10. UNIVAL(R), Inc. Becomes a Microsoft(R) HealthVault(TM) Application Provider
11. Dr. Gail Golab, Head of AVMA Animal Welfare Division, Becomes First U.S. Veterinarian Credentialed in Animal Welfare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , a ... today announced Cumberland Skin Surgery and Dermatology has joined the company ... in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin cancer ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... ... August 16, 2017 , ... Paul Vitenas, MD, FACS , is honored ... The annual list identifies the nation’s top physicians, in a variety of specialties. This ... the top of Castle Connolly’s coveted ranking. , Castle Connolly is the nation’s trusted ...
(Date:8/16/2017)... ... , ... A global leader in the treatment of clubfoot, CURE International ... states—bringing the country one step closer to eliminating clubfoot as a lifelong disability by ... track to enroll 10,000 children in the clubfoot treatment program in this year alone. ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... states: “Drying the endoscope after every reprocessing cycle, both between patient procedures and ... and nosocomial infections. Drying is as important to the prevention of disease transmission ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... 2017 EnvoyHealth, a Diplomat company, has partnered with ... CleverCap LITE, a technology designed to improve patient medication ... health technology solutions and services that help track and ... CleverCap LITE offers medication monitoring and control for ... Records date and time ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: